Maria Albin Selected Research

Biomarkers (Surrogate Marker)

1/2022	Cancer-related changes and low-to-moderate exposure to welding fumes: A longitudinal study.
12/2019	Mild steel welding is associated with alterations in circulating levels of cancer-related proteins.
1/2018	Exposure, respiratory symptoms, lung function and inflammation response of road-paving asphalt workers.
3/2016	Alterations of telomere length and DNA methylation in hairdressers: A cross-sectional study.
10/2015	Oxidative stress, telomere shortening, and DNA methylation in relation to low-to-moderate occupational exposure to welding fumes.
12/2013	Effects of diesel exposure on lung function and inflammation biomarkers from airway and peripheral blood of healthy volunteers in a chamber study.
1/2008	Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Albin Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 07/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2015
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2014
4	Inflammation (Inflammations) 06/2019 - 12/2013
3	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2008
2	Rhinitis 09/2016 - 05/2009
1	COVID-19 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2020
1	Pre-Eclampsia (Preeclampsia) 10/2020
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 10/2020
1	Carcinogenesis 12/2019
1	Mesothelioma 11/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2013
1	Eczema 03/2007

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
6	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2020 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 07/2005
4	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2009
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2018
2	SootIBA 10/2019 - 01/2017
2	AsbestosIBA 11/2018 - 01/2014
2	CarcinogensIBA 01/2018 - 07/2005
2	PowdersIBA 09/2016 - 05/2009
2	insulin receptor-related receptor (IRR)IBA 01/2011 - 03/2007
1	HomocysteineIBA 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	ORALIT (ORS)IBA 10/2020
1	CreosoteIBA 01/2020
1	fluoreneIBA 01/2020
1	SolventsIBA 01/2020
1	Chlorinated HydrocarbonsIBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 06/2019
1	Benzo(a)pyreneIBA 01/2019
1	benz(a)anthracene (benzanthracene)IBA 01/2019
1	pyreneIBA 01/2019
1	phenanthreneIBA 01/2019
1	Biological ProductsIBA 11/2018
1	asphaltIBA 01/2018
1	Isoflurophate (DFP)FDA Link 09/2016
1	SmokeIBA 12/2015
1	Prothrombin (Factor II)IBA 12/2015
1	protease-activated receptor 4IBA 12/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2015
1	DNA Glycosylases (DNA Glycosylase)IBA 05/2015
1	Interleukin-8 (Interleukin 8)IBA 05/2015
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 05/2015
1	PhytohemagglutininsIBA 01/2013
1	Styrene (Styrol)IBA 01/2012
1	Ethylene Oxide (Oxirane)IBA 01/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2008

Therapy/Procedure

1	Adjuvant Chemotherapy 01/2008